Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy

Journal of Surgical Oncology

Volumn 100, Issue 6, 2009, Pages 505-510

  Marana, Heitor Ricardo Cosiski ^a   De Andrade, Jurandyr Moreira ^a   Dos Reis, Francisco José Cândido ^a   Tiezzi, Daniel Guimarães ^a   Zola, Fábio Eduardo ^a   Clagnan, Willan Simões ^a   Garieri, Alexandre Pavan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cervical cancer; Chemotherapy; Lymph node dissection; Surgical staging

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAVA VEIN; CONTINUOUS INFUSION; CONTROLLED STUDY; CYSTIC LYMPHANGIOMA; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILIAC VEIN; LEG EDEMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; RADIATION ENTEROPATHY; STAGING; SURGICAL INFECTION; SURGICAL STAGING; THROMBOSIS; URETER INJURY; UTERINE CERVIX CANCER; VEIN INJURY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CASE-CONTROL STUDIES; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 70350303647     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21360     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, et al.: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
2. Stehman FB, Perez CA, Kurman RJ, et al.: Principles and practice of gynecologic oncology. New York: Lippincott-Raven; 1997.
3. Tanaka Y, Sawada S, Murata T: Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol Oncol 1984;23:455-459. (Pubitemid 15073560)
4. Van Nagell JR, Jr., Roddick JW, Jr., Lowin DM: The staging of cervical cancer: Inevitable discrepancies between clinical staging and pathologic findings. Am J Obstet Gynecol 1971;110:973-978.
5. Cosin JA, Fowler JM, Chen MD, et al.: Pretreatment surgical staging of patients with cervical carcinoma: The case for lymph node debulking. Cancer 1998;82:2241-2248.
6. Vasilev SA: A modified incision and technique for total retroperitoneal access and lymph node dissection. Gynecol Oncol 1995;56:226-230.
7. Denschlag D, Gabriel B, Mueller-Lantzsch C, et al.: Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Gynecol Oncol 2005;96:658-664. (Pubitemid 40255484)
8. Sedlis A, Bundy BN, Rotman MZ, et al.: A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group study. Gynecol Oncol 1999;73:177-183. (Pubitemid 29215728)
9. Greer BE, Koh WJ, Stelzer KJ, et al.: Expanded pelvic radiotherapy fields for treatment of local-regionally advanced carcinoma of the cervix: Outcome and complications. Am J Obstet Gynecol 1996;174:1141-1149.
10. Stryker JA, Mortel R: Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes. Gynecol Oncol 2000;79:399-405.
11. stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995;274(5):387-393
12. Downey GO, Potish RA, Adcock LL, et al.: Pretreatment surgical staging in cervical carcinoma: Therapeutic efficacy of pelvic lymph node resection. Am J Obstet Gynecol 1989;160:t-61.
13. Keys HM, Bundy BN, Stehman FB, et al.: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161. Erratum in: N Engl J Med 1999;341(9):708.
14. Rose PG, Bundy BN, Watkins EB, et al.: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153. (Pubitemid 29177873)
15. Hasenburg A, Salama JK, Van TJ, et al.: Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. Gynecol Oncol 2002;84:321-326. (Pubitemid 34136787)
16. Odunsi KO, Lele S, Ghamande S, et al.: The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer. Eur J Gynaecol Oncol 2001;22:325-330. (Pubitemid 33144535)
17. Goff BA, Muntz HG, Paley PJ, et al.: Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999;74:436-442. (Pubitemid 29439886)
18. Onnis A, Maggino T, Marchetti M: Surgery as diagnostic and therapeutic moment in the management of cervical cancer. Eur J Gynaecol Oncol 1985;6:20-30. (Pubitemid 15191695)
19. Lanvin D, Elhage A, Henry B, et al.: Accuracy and safety of laparoscopic lymphadenectomy: An experimental prospective randomized study. Gynecol Oncol 1997;67:83-87. (Pubitemid 27433333)
20. Querleu D, Dargent D, Ansquer Y, et al.: Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas. Cancer 2000;88:1883-1891. (Pubitemid 30212999)
21. Sonoda Y, Leblanc E, Querleu D, et al.: Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecol Oncol 2003;91:326-331. (Pubitemid 37346327)
22. Maduro JH, Pras E, Willemse PH, et al.: Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer [Review] [159 refs]. Cancer Treat Rev 2003;29:471-488.
23. Ayhan A, Tuncer ZS, Yarali H: Complications of radical hysterectomy in women with early stage cervical cancer: Clinical analysis of 270 cases. Eur J Surg Oncol 1991;17:492-494.
24. Savino L, Borruto F, Comparetto C, et al.: Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer. Eur J Gynaecol Oncol 2001;22:31-35. (Pubitemid 32242441)
25. Baalbergen A, Ewing-Graham PC, Hop WC, et al.: Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol Oncol 2004;92:262-267. (Pubitemid 38147402)
26. Morice P, Castaigne D, Pautier P, et al.: Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999;73:106-110. (Pubitemid 29177608)
27. Kim PY, Monk BJ, Chabra S, et al.: Cervical cancer with paraaortic metastases: Significance of residual paraaortic disease after surgical staging. Gynecol Oncol 1998;69:243-247. (Pubitemid 28289967)
28. Hacker NF, Wain GV, Nicklin JL: Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5:250-256.
29. Jolles CJ, Freedman RS, Hamberger AD, et al.: Complications of extended-field therapy for cervical carcinoma without prior surgery. Int J Radiat Oncol Biol Phys 1986;12:179-183.
30. Potish R, Adcock L, Jones T, Jr., et al.: The morbidity and utility of periaortic radiotherapy in cervical carcinoma. Gynecol Oncol 1983;15:1-9. (Pubitemid 13194677)
31. Varia MA, Ch B, Bundy BN, et al.: Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group Study. Int J Radiat Oncol Biol Phys 1998;42:1015-1023.
32. Perez CA, Hall EJ, Purdy JA, et al.: Biologic and physical aspects of radiation oncology. In: Hoskins WJ, Perez CA, Young RC, editors. Gynecologic oncology, 2nd edition. Philadelphia: Lippincott-Raven; 1997; pp. 305-380.
33. Fine BA, Hempling RE, Piver MS, et al.: Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery. Int J Radiat Oncol Biol Phys 1995;31:717-723.